glp-1 agonists
2 articles tagged with ‘glp-1 agonists’
Broad Opportunities in Polypeptide Drug Development
More than 7,000 natural polypeptides have been identified, playing roles in human physiology such as hormones and neurotransmitters. Therapeutic polypeptides are seeing renewed commercial interest after wide use in pharmaceuticals over the past decade. Advances in multifunctional peptides like GLP-1 agonists and cell-penetrating technologies promise expanded applications despite challenges.
Retatrutide Monthly Research Cost in Australia Breakdown
Researching Retatrutide (LY3437943), the most advanced triple GLP-1/GIP/glucagon receptor agonist, involves costs that vary by vial size, dose, and frequency. In Australia, a 10mg vial costs $129.99 AUD ($13.00/mg), while a 20mg vial is $199.99 AUD ($10.00/mg). Supplies like bacteriostatic water and needles add to monthly expenses, with planning around a 4-week reconstituted stability window essential to minimize waste.